MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G/A Report for Taysha Gene Therapies, Inc. Common Stock (TSHA)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Symbol
- TSHA
- Shares outstanding
- 251,621,552 shares
- Disclosed Ownership
- 16,858,644 shares
- Ownership
- 6.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Aug 2025, 14:13:20 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 05 Feb 2025
- SEC
- View on sec.gov
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 6.7% | 16,858,644 | 0 | 16,651,747 | Christopher O'Hara | Authorized Signatory, Morgan Stanley | |
| Morgan Stanley Capital Services LLC | 5.6% | 14,095,143 | 0 | 14,095,143 | Christopher O'Hara | Authorized Signatory, Morgan Stanley Capital Services LLC |